tirzepatide clinical trial enrollment Tirzepatide: First Approval | Drugs Effects of Tirzepatide on the

Menstrual changes during treatment are usually temporary and reverse after stopping the medication or allowing your weight to stabilize

Tirzepatide targets a second receptor called GIP in addition to GLP-1, which may lead to slightly greater weight loss in some patients

Stay alert to how your body feels during activity

it's a documented physiological response called tachyphylaxis, where your body gradually becomes less sensitive to the medication's appetite-suppressing and metabolic effects

These drugs reduce systolic blood pressure by about 2 to 6 points on average

2023 international evidence-based polycystic ovary syndrome guideline update: insights from a systematic review and meta-analysis on elevated clinical cardiovascular disease in polycystic ovary syndrome